Thermo Fisher Scientific Launches SpeciMAX Stabilized Saliva Collection Kit
New kit inactivates viruses, including SARS-CoV-2, for safer sample collection
CARLSBAD, Calif., Sept. 28, 2021 /PRNewswire/ -- As global SARS-CoV-2 research efforts continue, labs are increasingly conducting scientific studies using banked saliva samples, taking advantage of a sample type which is easy to access and non-invasive. To this end, Thermo Fisher Scientific has launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit*, which is designed to safely collect saliva for research.
The SpeciMAX Stabilized Saliva Collection Kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection. The kit comes with an easy-to-use, spill-resistant funnel, a screw cap to secure the sample after collection, and a standardized size tube that fits seamlessly into viral RNA extraction automation workflows for high throughput sample processing.
"Labs need a non-invasive and non-hazardous collection kit that works with their current instruments," said Ellie Mahjubi, vice president and general manager of sample preparation at Thermo Fisher Scientific. "SpeciMAX Stabilized Saliva Collection Kits are compatible with downstream automation workflows to help reduce the costs and time of viral research."
The stabilized solution is non-hazardous, does not contain guanidinium to avoid interaction with bleach and is compatible with all disinfection protocols. The stabilization agent preserves nucleic acid in saliva samples at ambient temperature for up to 14 days for RNA and viral nucleic acid, and up to two years for gDNA.
The new kit complements Thermo Fisher's recently launched SpeciMAX Saliva Collection Kit for raw saliva. Both products come individually packaged and barcoded, require just 1 mL of saliva and are a standardized 6 mL size to fit into downstream automation workflows.
The SpeciMAX Stabilized Saliva Collection Kit contains components that are manufactured under a license from Isohelix, a division of Cell Projects Limited.
For more information, please visit www.thermofisher.com/specimaxsaliva.
*For Research Use Only. Not for use in diagnostic procedures.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
Media Contact Information:
Mauricio Minotta
Phone: 760-805-5266
Email: [email protected]
Joanne Stanway
Phone: 978-273-1473
Email: [email protected]
SOURCE Thermo Fisher Scientific
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article